Cancer Causes Control 2005, 16:399–405.PubMedCrossRef 57. Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM: Risk of non-small cell eFT-508 manufacturer lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes Control 2005, 16:579–85.PubMedCrossRef 58. Raimondi S, Boffetta P, Anttila S, Bröckmoller J, Butkiewicz D, Cascorbi I: Metabolic gene polymorphisms and lung cancer risk in non-smokers.
An update of the GSEC study. Mutat Res 2005, 592:45–57.PubMedCrossRef 59. Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, AMPK activator Ankathil R: Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 2005, 50:618–27.PubMedCrossRef 60. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG: CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 2005, 26:2207–12.PubMedCrossRef 61. Adonis M, Martı’nez
V, Marı’n P, Gil L: CYP1A1 and GSTM1 genetic polymorphisms in lung cancer populations exposed to arsenic in drinking water. Xenobiotica 2005, 35:519–530.PubMedCrossRef 62. LI DR, Zhou QH, Guo ZL: Relationship between genetic polymorphism of CYP1A1 and lung cancer genetic susceptibility [in Chinese]. Chin J Cancer Prev Treat 2006, 13:1765–1768. 63. Pisani P, Srivatanakul P, Randerson-Moor J, Vipasrinimit S, Lalitwongsa S, Unpunyo P, Bashir S, Bishop DT: GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural selleck chemicals Thailand. Cancer Epidemiol Biomarkers Prev 2006, 15:667–74.PubMedCrossRef 64. Belogubova EV, Ulibina YM, Suvorova IK: Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects. J Cancer Res Clin Oncol 2006, 132:327–331.PubMedCrossRef 65. Jin Y, Yu Z: The effects of CYP1A1 gene polymorphism and p16 gene methylation on the risk of lung cancer [in Chinese]. Acta of Anhui medical University 2007, 42:62–66. 66. Qi XS, Xia Y, Sun QF,
Shang B: Association between genetic Polymorphisms ofCYP1A1and Lung Cancer Susceptibility Olopatadine for People Living in High Radon-exposed Area [in Chinese]. Carcinogenesis Teratogenesis and Mutagenesis 2007, 20:11–14. 67. Yang M, Choi Y, Hwangbo B, Lee JS: Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 2007, 57:135–42.PubMedCrossRef 68. Cote ML, Wenzlaff AS, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG: Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Lung Cancer 2007, 55:255–62.PubMedCrossRef 69. Xia Y, Sun QF, Shang B: Polymorphisms of the cytochrome P450 and ghtathion s-transferase genes associated with lung cancer susceptibility for the residents in high radon-exposed area [in Chinese]. Chin J Radiol Med Prot 2008, 28:327–332. 70.